ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025

Company Overview - ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing, and developing specialty biologics for immunodeficient patients and those at risk for infectious diseases [3] - The company currently manufactures and markets three FDA-approved plasma-derived biologics: BIVIGAM, ASCENIV™, and NABI-HB, targeting immune deficiencies and prevention of certain infectious diseases [3] - ADMA operates an FDA-licensed plasma fractionation and purification facility in Boca Raton, Florida, and also runs ADMA BioCenters, an FDA-approved source plasma collector [3] Upcoming Events - Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, from January 13-16, 2025, with ADMA's presentation scheduled for January 13, 2025, at 10:30 a.m. PT [1] - A live audio webcast of the presentation will be available on the company's investor website, with an archived version accessible approximately two hours after the event [2]